Sanofi Aventis U S Inc | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Sanofi Aventis U S Inc

Sort by

Viewing results 1‒25 of 893

High yield bonds
Is it PIK-up time for cash-strapped companies?
...But, as S&P puts it when explaining why U.S....
February 21, 2024
Investments
Behold, the Basquiat bond
...ArtFi 2024-1’s prospectus has further detail on the collateral backing the deal, which it notes can include “fine art, collectibles, design furniture, coins, books, jewelry, watches, wine or other spirits...
April 12, 2024
FT Live
FTWeekend Festival: U.S. edition
The Saturday where the Financial Times Weekend paper comes to life
Saturday, 10 May 2025The REACH, at the Kennedy Center for the Performing Arts, F Street Northwest, Washington, DC, USA
Skechers USA Inc
Skechers’ family troubles
...In last night from the SEC: The Securities and Exchange Commission today [Thursday] announced that Skechers U.S.A....
March 8, 2024
Energy Source
Oil and gas executives expect slower transition to net zero Premium content
...The slower expectations for the transition come as companies make U-turns on their climate pledges and governments double down on fossil fuels amid energy security concerns....
March 14, 2024
Investing in funds
Back into the active/passive trenches
...S&P Dow Jones Indices, September 21, 2023: Look, the Morningstar report that Institutional Investor cites is as legit as the SPIVA scorecard from S&P DJI....
September 21, 2023
ESG investing
S&P drops ESG scores from debt ratings amid scrutiny
...The U-turn puts S&P at odds with debt rating rival Moody’s, which still rates ESG criteria on a one to five scale. S&P is influential, with debt ratings that can affect a company’s borrowing cost....
August 8, 2023
FT Live
Decarbonising India's Industries
Unlocking the technologies and capital required to accelerate progress
Tuesday, 11 JuneDigital Conference
Scoreboard
Hollywood comes for Formula One Premium content
...The price has been pushed up by F1’s booming popularity in the US, and also the sport’s new spending caps that have put a lid on costs....
July 1, 2023
Sovereign bonds
PSA: no one should care about the US credit rating
...risks to U.S. creditworthiness. . . ....
May 25, 2023
Energy sector
Bets on energy transition spark rise in North American pipeline deals
...“They’re taking bets on different things,” said Raoul LeBlanc, an analyst at S&P Global....
September 23, 2023
Digital currencies
The Crypt, updated
...s=46&t=uS_p1jt3N5TYYYWqkDeEiw Also 15 November 2022: “Bnk To The Future (the ‘Company’) announces that its previously announced non-binding letter of intent with SALT Blockchain, Inc....
August 16, 2023
LexAmgen Inc
Amgen/Horizon: swoop on rare disease specialist will push up debt load Premium content
...To beat out Johnson & Johnson and Sanofi, Amgen will be paying nearly 45 times EV to ebitda for Horizon. The wider S&P Biotech index trades on a multiple of 11.4 times....
December 12, 2022
Television
Everything you don’t actually need to know about the economics of Succession
...Splitting them along S3E5’s proxy vote battle lines: Team Logan We’re told the family holds 36 per cent of Waystar....
April 21, 2023
FT Asset Management
Asset management: Fallout from the Adani Group
...Companies included in the blue-chip S&P 500 index are expected to post a combined 5.3 per cent year on year fall in earnings for the final three months of 2022, according to FactSet....
February 6, 2023
UK public finances
Second rating agency cuts UK outlook in wake of mini-Budget
...The rating agency maintained the UK’s AA- investment grade but warned that the outlook was now negative rather than stable, mirroring the action taken last week by its peer S&P....
October 5, 2022
FT Alphaville
Further Reading
...U.S....
August 12, 2022
FT Live
Investing in America
Foreign companies as drivers of US growth, resilience and competitiveness
Tuesday, 10 DecemberHybrid Conference
FT AlphavilleJamie Powell
Affirm’s ABS: canary in the coal mine? (update)
...From Bloomberg on Friday: Affirm, the leading U.S....
March 14, 2022
The Top LineTom Braithwaite
Why Pfizer has won the Covid vaccine race but isn’t getting credit
...It has even underperformed the S&P 500, and by a considerable margin....
October 15, 2021
Covid-19 vaccines
The next generation Covid-19 vaccines seeking a slice of the market
...Several are more traditional shots, like the jab under development at GSK and Sanofi, that were leapfrogged by 2020’s breakthrough mRNA jabs....
June 11, 2021
FT News Briefing podcast10 min listen
US businesses pull donations, Turkey’s quest for power
...U-S corporations are reviewing their political donations after the attack on the Capitol building, and research has found the huge global cyber espionage campaign discovered last month was carried out using...
January 12, 2021
Pharmaceuticals sector
Sanofi sells half of its Regeneron stake for $6.1bn
...The S&P 500 has fallen nearly 12 per cent over the same period, while Sanofi’s stock has dropped 7 per cent....
May 27, 2020
Drugs research
Sanofi to slash $12bn stake in US biotech Regeneron
...The public offering comes as Regeneron shares are trading near all-time highs, having risen 82 per cent in the past year and outperforming the S&P 500 index’s 4.5 per cent rise in the same period....
May 25, 2020
ETF HubLatest news on ETFs
BlackRock S&P 500 fund is Europe’s biggest equity ETF loser in third quarter
...“iShares Core S&P 500 and Vanguard S&P 500 are both physical ETFs. Some investors in these funds have switched to synthetic competitors.”...
October 9, 2020
Streaming services
Amazon and Netflix look beyond Bollywood for India’s next big hit
...Malayalam-language Jallikattu, India’s official entry to 2021’s Academy Awards, was streamed on Amazon Prime Video....
January 1, 2021
News in-depthTelecoms
Telecoms networks look to fix Huawei problem with open source software
...Brendan O’Reilly, O2’s chief technology officer, said he had visited Rakuten in Tokyo and that OpenRAN would play a “vital role” in future networks. O2 is running trials in two locations in the UK....
July 27, 2020
Johnson & Johnson Co Inc
J&J lifts dividend but cuts 2020 guidance on coronavirus uncertainty
...Other contenders in the race to develop the first Covid-19 vaccine include GlaxoSmithKline, Sanofi, Pfizer and Boston-based biotech Moderna....
April 14, 2020

Previous pagePage 1 of 36Next page